Xtx Topco LTD Athira Pharma, Inc. Transaction History
Xtx Topco LTD
- $2.23 Billion
- Q2 2025
A detailed history of Xtx Topco LTD transactions in Athira Pharma, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 52,986 shares of ATHA stock, worth $218,302. This represents 0.0% of its overall portfolio holdings.
Number of Shares
52,986
Previous 46,148
14.82%
Holding current value
$218,302
Previous $12,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ATHA
# of Institutions
58Shares Held
18.5MCall Options Held
24.1KPut Options Held
0-
Perceptive Advisors LLC New York, NY5.4MShares$22.3 Million0.07% of portfolio
-
Bml Capital Management, LLC Zionsville, IN3.23MShares$13.3 Million0.74% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.54MShares$6.34 Million0.0% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA1.49MShares$6.15 Million0.55% of portfolio
-
Simplify Asset Management Inc. New York, NY1.49MShares$6.15 Million0.03% of portfolio
About Athira Pharma, Inc.
- Ticker ATHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,817,700
- Market Cap $156M
- Description
- Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...